Latest Monoamine oxidase inhibitor Stories
New generation antidepressants, known as selective serotonin reuptake inhibitors (SSRIs) are associated with an increased risk of several severe adverse outcomes in older people compared with older tricyclic antidepressants (TCAs).
ABBOTT PARK, Ill., Oct. 8 /PRNewswire/ -- Abbott (NYSE: ABT) will voluntarily withdraw MeridiaÂ® (sibutramine) from the U.S. market at the request of the U.S. Food and Drug Administration (FDA).
ABBOTT PARK, Ill., Sept. 15 /PRNewswire-FirstCall/ -- The U.S.
PHILADELPHIA, May 22 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced results of a study showing that coadministration of the ADHD medication VYVANSE(R) (lisdexamfetamine dimesylate) CII with the proton pump inhibitor (PPI) Prilosec OTC(R) 40 mg (20 mg X 2), did not alter the median time it took for maximum plasma concentration of d-amphetamine to be reached in the subjects evaluated.
NEW YORK and SAN DIEGO, April 20, 2009 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) and Cypress Bioscience, Inc.
New treatment option for the estimated 6 million Americans living with this chronic, debilitating condition NEW YORK and SAN DIEGO, Jan. 14, 2009 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) and Cypress Bioscience, Inc.
WASHINGTON (Reuters) - The use of some migraine drugs with certain antidepressants can cause a fatal condition in which patients experience hallucinations, overactive reflexes and rapid heart beat, the U.S. Food and Drug Administration warned on Wednesday.
Researchers from Harvard Medical School have found a molecule that is unexpectedly involved in dopamine signaling, and in a manner that supports the potential of dopamine as an alternative target for treating depression. The results provide evidence that there is a molecular link between impaired dopamine signaling and depression, which affects 16 percent of the adult population in the United States. The research appears in the July 29 issue of Cell.
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.